
Frontline BioVentures
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Frontline BioVentures is a premier China-based venture capital firm specialize in the investment of innovative life science companies We
Investor Profile
Frontline BioVentures has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (38%)
- Series C (25%)
- Series Unknown (25%)
- Secondary Market (13%)
Country Focus
- China (63%)
- United States (38%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Manufacturing
- Life Science
- Biopharma
- Therapeutics
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.